Immunitybio shares owned by Cambridge Investment Research Advisors
Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Cambridge Investment Research Advisors
from 13F filings
Historical chart of Cambridge Investment Research Advisors investment in Immunitybio
Tip: Access up to 7 years of quarterly data
All positions including Immunitybio held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Immunitybio by Cambridge Investment Research Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $173k | 70k | 2.46 |
| 2025-06-30 | $55k | 21k | 2.63 |
| 2025-03-31 | $54k | 18k | 3.01 |
| 2024-09-30 | $54k | 15k | 3.72 |
| 2024-06-30 | $87k | 14k | 6.30 |
| 2024-03-31 | $78k | 15k | 5.40 |
| 2023-12-31 | $75k | 15k | 5.02 |
| 2023-09-30 | $25k | 15k | 1.67 |
| 2023-06-30 | $42k | 15k | 2.81 |
| 2023-03-31 | $25k | 14k | 1.79 |
| 2022-12-31 | $61k | 12k | 5.10 |
| 2021-06-30 | $408k | 29k | 14.28 |
More positions owned by Cambridge Investment Research Advisors
View all positions for Cambridge Investment Research Advisors